Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06285812 · ClinicalTrials.gov registry record
Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children
A clinical trial of Otitis Media Acute, sponsored by PhotoniCare.
- Active
- Registry status
- 700
- Enrollment target
- 7
- Study locations
NCT06285812 is a study of Otitis Media Acute that is active but no longer recruiting, run by PhotoniCare. The registered enrollment target is 700 participants. The trial reports 7 study locations across 6 states.
The verdict
NCT06285812, a study of Otitis Media Acute, is active but no longer recruiting, sponsored by PhotoniCare.
- ACTIVE NOT RECRUITING
- Registry status
- 700 participants
- Enrollment target
- 7
- Study locations
Study Summary
A pragmatic, mixed-method trial is to show the ability of OtoSight to change management of the pediatric patient presenting with ear pain in a way that improves patient outcomes and reduces costs.
Conditions Studied
Interventions
- DEVICE OtoSight Middle Ear Scope
Study Locations (7)
Florida
- Abba Medical Group LLC - Miami
- AdventHealth Children's Research - Orlando
District of Columbia
- Children's National Hospital - Washington D.C.
New York
- Trillim Health - Rochester
Oregon
- Cyn3rgy Research - Gresham
South Carolina
- Carolina ENT - Orangeburg
Tennessee
- HealthStar Physicians - Morristown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2024-01-10 |
| Est. Completion | 2025-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06285812
The ClinicalTrials.gov registry entry for NCT06285812 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PhotoniCare, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Otitis Media Acute appearing as the primary indexed condition, and to 1 intervention - of which OtoSight Middle Ear Scope is the first listed.
NCT06285812 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Florida, District of Columbia, New York.
Frequently Asked Questions
What is clinical trial NCT06285812 about?
NCT06285812 is a clinical study titled "Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children". A pragmatic, mixed-method trial is to show the ability of OtoSight to change management of the pediatric patient presenting with ear pain in a way that improves patient outcomes and reduces costs.
What is the current status of trial NCT06285812?
This trial is currently active not recruiting. The enrollment target is 700 participants. The study started on 2024-01-10. Estimated completion is 2025-12-30.
What conditions does trial NCT06285812 study?
This clinical trial studies the following conditions: Otitis Media Acute.
What interventions are being tested in trial NCT06285812?
The interventions under investigation include: OtoSight Middle Ear Scope (DEVICE).
Who is sponsoring clinical trial NCT06285812?
This trial is sponsored by PhotoniCare, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06285812 being conducted?
This trial has 7 study locations across District of Columbia, Florida, New York, Oregon, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Otitis Media Acute
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.